Generics urge US Supreme Court to implement Copaxone ruling


Generic drug makers Sandoz, Mylan and Natco have asked the US Supreme Court to immediately put into effect its ruling on the validity of a patent covering Teva’s multi-billion dollar multiple sclerosis drug Copaxone.

Copaxone, US Supreme Court, Teva, Sandoz, Federal Circuit